Last reviewed · How we verify

NCT04933045

Treatment of Syndesmotic Disruption With Anatomic Distal Tibiofibular Ligament Augmentation

Status unknown Last updated 21 June 2021
What this trial tests

trial testing Arthrex InternalBrace in Syndesmotic Injuries in 32 participants. Status unknown.

Timeline
1 July 2021
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorSt. Clair Orthopaedics
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment32
Start date1 July 2021
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

St. Clair Orthopaedics

Who can join

Adults 18 to 105, any sex, with Syndesmotic Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to evaluate indications and outcomes of operative fixation of syndesmotic injuries, at least in part, with direct anatomic augmentation in acute and subacute traumatic cases. The secondary objective of the study is to evaluate clinically the InternalBraceTm to facilitate the direct syndesmotic fixation/augmentation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Arthrex InternalBrace

Trials testing the same drug.

Other recruiting trials for Syndesmotic Injuries

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04933045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing